The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study

Gynecologic Oncology
John K ChanJeffrey Bell

Abstract

A prior clinical trial on early-stage high risk ovarian cancer showed a lower recurrence rate in those treated with six vs. three cycles of chemotherapy. We proposed to identify subsets of patients who may benefit from more cycles of chemotherapy. Outcomes of patients who underwent six vs. three cycles of chemotherapy were analyzed based on clinico-pathologic factors. Kaplan-Meier estimates and Cox Regression Model were used for analyses. Of 427 patients (median age: 55 years), 69% had stage I disease, 30% had clear cell, 25% endometrioid, 23% serous, 7% mucinous, and 15% had other cell types. The risk of recurrence in those who had six vs. three cycles of chemotherapy was not different based on age, performance status, stage, grade of disease, presence of ascites, tumor rupture, or positive cytology. However, those with serous tumors had a significantly lower risk of recurrence after six vs. three cycles of chemotherapy (HR=0.33, CI=0.14-0.77; p=0.04) in contrast to non-serous tumors (HR=0.94, CI=0.60-1.49). Nevertheless, a test of homogeneity did not show a difference in treatment effects across cell types (p=0.285). Of those with serous tumors, the 5-year recurrence-free survival was 83% and 60% in those who received six vs....Continue Reading

References

Jul 1, 1993·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. BertelsenP. Ladehoff
Jul 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P.J. HoskinsJ. Le Richer
Sep 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. SjövallN. Einhorn
Jan 17, 2003·Journal of the National Cancer Institute·J Baptist TrimbosUNKNOWN EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neop
Jan 17, 2003·Journal of the National Cancer Institute·Nicoletta ColomboUNKNOWN International Collaborative Ovarian Neoplasm (ICON) collaborators
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert C YoungDavid S Alberts
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca T MarquezKaren H Lu
Mar 7, 2006·Gynecologic Oncology·Dimitrios PectasidesMeletios A Dimopoulos
Jan 30, 2007·Human Pathology·Julia WillnerElizabeth M Swisher
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Oct 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A LedermannUNKNOWN ESMO Guidelines Working Group
May 4, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A Bookman
Sep 8, 2010·Seminars in Oncology·Abdalla SholiGloria J Morris
Jan 17, 2012·Hematology/oncology Clinics of North America·John O SchorgeDennis S Chi
Feb 24, 2015·Gynecologic Oncology·Helen E DinkelspielJason D Wright
Oct 5, 2015·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jonathan S BerekMichael Friedlander
Dec 29, 2016·Best Practice & Research. Clinical Obstetrics & Gynaecology·Kate Webber, Michael Friedlander
Dec 18, 2016·Best Practice & Research. Clinical Obstetrics & Gynaecology·Patricia J Eifel
Oct 4, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jonathan S BerekMichael Friedlander
Jun 15, 2018·BJOG : an International Journal of Obstetrics and Gynaecology·A T TsunodaFjf Coimbra
Oct 12, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jonathan S BerekMichael Friedlander
Jul 18, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Mika MizunoFumitaka Kikkawa
Jan 11, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Mubiao LiuYing Ma
Sep 5, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Aalok KumarPaul J Hoskins
Feb 2, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angiolo GadducciEnrico Sartori
Oct 3, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Bryan D MacrieWilliam Small
Jan 31, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Antonino DittoFrancesco Raspagliesi
May 3, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N ColomboUNKNOWN ESMO–ESGO Ovarian Cancer Consensus Conference Working Group
May 3, 2014·Obstetrics and Gynecology·Koji MatsuoAnil K Sood
Feb 22, 2012·Clinical Obstetrics and Gynecology·Leigh G SeamonLarry J Copeland
Jun 2, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Derya Kilic SakaryaDemir Ozbasar
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Stefano UccellaRobert L Coleman
Aug 14, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charlie Gourley, Michael A Bookman
Jun 25, 2015·Current Opinion in Obstetrics & Gynecology·Hooman Soleymani MajdRoberto Tozzi
Apr 19, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jamie N Bakkum-GamezWilliam A Cliby
Nov 11, 2020·BMJ : British Medical Journal·Lindsay Kuroki, Saketh R Guntupalli
May 3, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO-ESGO Ovarian Cancer Consensus Conference Working Group
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO-ESGO Ovarian Cancer Consensus Conference Working Group
Apr 29, 2021·Journal of Gynecologic Oncology·Majdi Imterat, Philipp Harter
Sep 26, 2015·Gynecologic Oncology·Catherine A ShuCarol A Aghajanian
Sep 28, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A OseledchykO Zivanovic
Sep 28, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D Lorusso, S Pignata
Jul 17, 2021·Journal of Surgical Oncology·Paulina CybulskaMario M Leitao
Sep 25, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Soumyajit RoyGaurav Bahl
Feb 6, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Deborah K ArmstrongAnita M Engh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Journal of the National Cancer Institute
J Baptist TrimbosEORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neop
© 2022 Meta ULC. All rights reserved